Author reply – Corrected Proof

Esmaeli's request for clarification of issues regarding our study involves 11 points related to both the intra-arterial cytoreductive chemotherapy (IACC) protocol design and our analysis. First, the introductory quotation attributed to us was not a statement made in our manuscript. Eight patients were in group 1, not 7, and the characterization of group 2 patients as only those without an intact lacrimal artery is inaccurate. We address each query sequentially.

Full Story →